ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF PSEUDOMONAS AERUGINOSA CLINICAL ISOLATES AT A TERTIARY CARE HOSPITAL IN KATHMANDU, NEPAL
Objective: Increasing Â number of reports had documented the continued emergence of resistance among P. aeruginosa strains to commonÂ antimicrobial Â drugs, world-wide. This study investigated the antimicrobial resistance patterns of P. aeruginosa clinical isolates obtained from hospitalized patients.
Methods: Between January 2012 and June 2012, one hundred and forty-five strains of P.aeruginosa were isolated from different clinical specimens Â Â and fully characterized by standard bacteriological procedures. Antimicrobial susceptibility patterns of each isolate was carried out by the Kirby- Bauer disk diffusion method as per guidelines of CLSI.
Results: Majority of isolates of P.aeruginosa (120, 83.75%) were obtained from specimens of pus, sputum, urine and tracheal aspirates. The isolated pathogens showed resistance to amikacin (17.25%), ciprofloxacin (27.59%) and cefoperazone -sulbactum (34.48%). Â Resistance rates to Co-trimoxazole, piperacillin, ceftriaxone and chloramphenicol varied from 51.00% to 73.00%. All the isolates were susceptible to imipenem. 30 (20.69%) of P.aeruginosa isolates were multi-drug resistant.
Conclusion: The results confirmed the occurrence Â ofÂ drug resistant strains of P.aeruginosa. Imipenem, amikacin, and ciprofloxacin were found to be the most effective antimicrobial drugs. It therefore calls for a very judicious, rational treatment regimens prescription by the physicians to limit the further spread of antimicrobial resistance among the P.aeruginosa strains.
Keywords: antimicrobial resistance, clinical isolates, Nepal, Pseudomonas aeruginosa
2. Carmeli Y, Troillett N, Karchmer AW, Samore MH. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999;159:1127-32.
3. Acar JF. Conequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis 1997;24(suppl1):S17-S18.
4. Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiology 2011;2:1-13.
5. Kerr KG, Snelling AM. Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect 2009;73:338-44.
6. Zhao WH, Hu ZQ. Î²- lactamases identified in clinical isolates of Pseudomonas aeruginosa. Crit Rev Microbiol 2010;36:245-58.
7. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005;49:479-87.
8. Strateva T, Yordanov D. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 2009;58:1133-48.
9. Davies JC, Bilton D. Bugs, biofilms and resistance in cystic fibrosis. Respir care 2009;54:628-40.
10. Oliver A, Mena A. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin Microbiol Infect 2010;16:798-808.
11. Koirala P, Bhatta DR, Ghimire P, Pokhrel BM, Devkota U. Bacteriological profile of tracheal aspirates of the patients attending a neuro-hospital of Nepal. Int J Life Sci 2010;4:60-65.
12. Bhandari S, Banjara MR, Lekhak B, Bhatta DR, Regmi SR. Multi-drug and pan-drug resistant Pseudomonas aeruginosa: a challenge in post-antibiotic era. Nepal J Sci Tech 2012;13(2):197-202.
13. Collee JG, Miles RS, Watt B. Tests for identification of bacteria. In: Collee JG, Duguid JP, Fraser AG, Marmion BP, eds. Mackie and MacCartney Practical Medical Microbiology. 14th ed. New York: USA: Churchill Livingstone;1996, p. 131-149.
14. National Committee for Clinical Laboratory Standards. NCCLS document M2-A8 Vol. 23 No. 1, Performance standards for antimicrobial disk susceptibility tests, approved standard, 8th ed. 2003. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Rajat RM, Ninama GL, Mistry K, Parmar R, Patel K, Vegad MM. Antibitic resistance pattern in Pseudomonas aeruginos species isolated at a tertiary care hospital, Ahmadabad. National J Med Res 2012;2(2):156-59.
16. Ahmed SM, Jakribettu RP, Kottakutty S, Arya B, Shakir VPA. An emerging multi-drug resistant pathogen in a tertiary care centre in North Kerala. Annals Biol Res 2012;3(6):2794-99.
17. Mohanasoundaram KM. The antibiotic resistance pattern in the clinical isolates of Pseudomonas aeruginosa in a tertairy care hospital; 2008-2010 (A 3 year study). J Clin Diagn Res 2011;5(3):491-94.
18. Arora D, Jindal N, Kumar R, Romit. Emerging antibiotic resistance in Pseudomonas aeruginosa. Int J Pharm Pharm Sci 2011;3(2):82-4.
19. Orrett FA. Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources. J Natl Med Assoc 2004;96(8):1065-69.
20. Chen HY, Yuan M, Livermore DM. Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the United Kingdom in 1993. J Med Microbiol 1995;43: 300-09.
21. Shenoy S, Baliga S, Saldanha DR, Prashanth HV. Antibiotic sensitivity patterns of Pseudomonas aeruginosa strains isolated from various clinical specimens. Indian J Med Sci 2002;56(9):427-30.
22. Javiya JA, Ghatak SB, Patel KR, Patel JA. Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India. Indian J Pharmacol 2008;40(5):230-34.
23. Al-Kabsi AM, Yusof MYBM, Sekaran SD. Antimicrobial resistance pattern of clinical isolates of Pseudomonas aeruginosa in the University of Malaya Medical Center, Malaysia. Afr J Microbiol Res 2011;5(29):5266-72.
24. Rashid A, Chowdhury A, Rahman SHZ, Begum SA, Muazzam N. Infections by Pseudomonas aeruginosa and antibiotic resistance pattern of the isolates from Dhaka Medical College Hospital. Bangladesh J Med Microbiol 2007;1(2):48-51.
25. Savas L, Duran N, Savas N, Onlen Y, Ocak S. The prevalence ans resistance pattterns of Pseudomonas aeruginosa in intensive care units in a university hospital. Turk J Med Sci 2005;35:317-22.
26. Fazlul MKK, Zaini MZ, Rashid MA, Nazmul MHM. Antibiotic susceptibility profile s of clinical isolates of Pseudomonas aeruginosa from Selayang Hospital, Malaysia. Biomed Res 2011;22(3):263-66.
27. Al-Tawfiq JA. Occurrence and antimicrobial resistance pattern of inpatient and outpatient isolates of Pseudomonas aeruginosa in a Saudi Arabian hospital: 1998-2003. Int J Infect Dis 2007;11:109-14.
28. Nwankwo EOK, Shuaibo SA. Antibiotic susceptibility patttern of clinical isolates of Pseudomonas aeruginosa in a tertairy health institution in Kano, Nigeria. J Med Biomed Sci 2010;37-40.
29. Ramana BV, Chaudhury A. Antibiotic resistance patttern of Pseudomonas aeruginosa isolated from healthcare associated infections at a tertiary care hospital. J Sci Soc 2012;39:78-80.
30. Pathmanathan SG, Samat NA, Mohamed R. Antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from a Malaysian hospital. Malays J Med Sci 2009;16(2):27-32.
31. Moazami-Goudarzi S, Eftekhar F. Assessment of carbapenem susceptibility and multidrug-resistance in Pseudomonas aeruginosa burn isolates in Tehran. Jundishapur J Microbiol 2013;6(2):162-65.
32. Anjum F, Mir A. Susceptibility pattern of Pseudomonas aeruginosa against various antibiotics. Afr J Microbiol Res 2010;4(10):1005-12.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.